Expression and function of myelin expression factor 2 in hepatocellular carcinoma
Abstract Introduction Hepatocellular carcinoma (HCC) is one of the most common malignant tumours in the world and has a high mortality rate. However, the pathogenesis of HCC remains unclear. This study aimed to investigate the potential biomarkers of HCC. Methods ONCOMINE, HCCDB and THE HUMAN PROTEI...
Main Authors: | Peng Zhang, Jiang-Hua Zhao, Lin Chen, Zhao-Lian Bian, Lin-Ling Ju, Hui-Xuan Wang, Wei-Hua Cai |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-01-01
|
Series: | BMC Gastroenterology |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12876-023-02644-3 |
Similar Items
-
Enhanced expression of miR-889 forecasts an unfavorable prognosis and facilitates cell progression in hepatocellular carcinoma
by: He Wang, et al.
Published: (2021-06-01) -
Ethanolamine-phosphate phospho-lyase (ETNPPL) contributes to the diagnosis, prognosis, and therapy of hepatocellular carcinoma
by: Yun Zhang, et al.
Published: (2023-08-01) -
PRAF2 expression indicates unfavorable clinical outcome in hepatocellular carcinoma
by: Wang CH, et al.
Published: (2018-07-01) -
Expression and Role of Integrin β-like 1 in Hepatocellular Carcinoma
by: LIN Liyan, et al.
Published: (2022-12-01) -
Overexpression of RALY promotes migration and predicts poor prognosis in hepatocellular carcinoma
by: Zhu Z, et al.
Published: (2018-11-01)